Auteur K. MOELLER

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Coordination problems in cryptomarkets: Changes in cooperation, competition and valuation

S. ANDERDAL BAKKEN ; K. MOELLER ; S. SANDBERG | 2018
Dans European Journal of Criminology (Vol.15, n°4, July 2018) Article : Périodique

The new drug markets emerging on the dark net have reduced earlier drug market risk factors such as visibility and violence. This study uses economic sociology and transaction cost economics to broaden the present understanding of cryptomarkets.[...]

Plus d'info

Ajouter à la sélection

Estimating drug policy expenditures: Direct costs of policing cannabis in Copenhagen 2000-2009

K. MOELLER | 2012
Dans Drugs: Education, Prevention and Policy (Vol.19, n°5, October 2012) Article : Périodique

Aim: To establish estimates for the direct costs of policing cannabis in Copenhagen. Methods: Policing is disaggregated into the two tactical components of retail-level policing and crackdowns. Costs for retail-level policing are estimated usi[...]

Plus d'info

Ajouter à la sélection

Lien externe

Hybrid governance in online drug distribution

K. MOELLER | 2022
Dans Contemporary Drug Problems (Vol.49, n°4, December 2022) Article : Périodique

A growing share of illicit drug dealing occurs on online platforms. Technological innovations, such as encryption and anonymous payments, have enabled new and more complex ways of organizing transactions. This conceptual essay advances the study[...]

Plus d'info

Ajouter à la sélection

Lien externe

Illicit drug prices and quantity discounts: A comparison between a cryptomarket, social media, and police data

K. MOELLER ; R. MUNKSGAARD ; J. DEMANT | 2021
Dans International Journal of Drug Policy (Vol.91, May 2021) Article : Périodique

Background: Illicit drugs are increasingly sold on cryptomarkets and on social media. Buyers and sellers perceive these online transactions as less risky than conventional street-level exchanges. Following the Risks & Prices framework, law enfor[...]

Plus d'info

Ajouter à la sélection

Revisiting Goldstein's drugs-violence nexus: Expanding the framework for the globalized era

M. LIEM ; K. MOELLER | 2025
Dans International Criminology (Vol.5, n°1, March 2025) Article : Périodique

In 1985, Goldstein developed a framework to capture the relationships between drugs and violence in the United States, laying a foundation for future research on drug-related violence. Since then, the rise of synthetic drugs, including in Europe[...]

Plus d'info

Ajouter à la sélection

Lien externe

"Shop until you drop": Valuing fentanyl analogs on a Swedish Internet forum

K. MOELLER ; B. SVENSSON | 2021
Dans Journal of Drug Issues (Vol.51, n°1, January 2021) Article : Périodique

Fentanyl analogs are synthetic opioids used for pain treatment and palliative care, which are also sought after by drug users for their psychoactive properties. Clandestinely produced fentanyl has caused an overdose crises of unprecedented scale[...]

Plus d'info

Ajouter à la sélection

The double effect of COVID-19 confinement measures and economic recession on high-risk drug users and drug services [Editorial]

C. COSTA STORTI ; A. L. BRETTEVILLE-JENSEN ; P. DE GRAUWE ; K. MOELLER ; J. MOUNTENEY ; A. STEVENS | 2021
Dans European Addiction Research (Vol.27, n°4, June 2021) Article : Périodique

The ongoing COVID-19 pandemic is likely to have a profound impact on the lives of high-risk drug users and on the services responding to their needs in at least two important ways: first, through the restrictive measures introduced to mitigate t[...]

Plus d'info

Ajouter à la sélection

Lien externe

The importance of co-produced, multi-method, independent scientific evidence in times of alternative truths and global policy debates

C. COMISKEY ; H. BERGERON ; T. CLAUSEN ; C. COLMAN ; L. FERRER-WREDER ; G. FISCHER ; M. G. DE MATOS ; J. H. IVERS ; M. JAUFFRET-ROUSTIDE ; M. LIEM ; T. LINTONEN ; K. MOELLER ; I. OJANPERA ; F. R. DE FONSECA ; M. T. MELICH | 2024
Dans International Journal of Drug Policy (Vol.129, July 2024) Article : Périodique

In July 2024 the long established and trusted European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) will cease to exist and will evolve to the new European Drugs Agency (EUDA). In response to the ever diversifying, innovative and comp[...]

Plus d'info

Ajouter à la sélection

Lien externe